• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于同时检测脂蛋白相关磷脂酶A(Lp-PLA)和超敏C反应蛋白(HsCRP)的用于筛查冠状动脉粥样硬化的双标记时间分辨荧光免疫分析(TRFIA)。

A dual-label time-resolved fluorescence immunoassay (TRFIA) for screening of Coronary atherosclerosis based on simultaneous detection of Lp-PLA and HsCRP.

作者信息

Zhang Zhong, Liu Xiaozhu, Li Yinfeng, Huang Ruolan, Wang Ling, Li Laiqing, Chen Cuicui, Ou Lijun, Chang Xiao, Qiao Qiujie, Chen Mingtai

机构信息

Department of Cardiovascular, Shenzhen Chinese Traditional Medical Hospital, Shenzhen 518033, Guangdong, China.

School of Light Industry Engineering, Guizhou Institute of Industry, Guiyang, 550000, China.

出版信息

Immunol Lett. 2017 Feb;182:12-17. doi: 10.1016/j.imlet.2016.12.004. Epub 2016 Dec 23.

DOI:10.1016/j.imlet.2016.12.004
PMID:28025044
Abstract

Atherosclerosis is the underlying cause of most coronary events. The conventional method for coronary atherosclerosis detection is morphological examination or coronary arterionyraphy. These methods are complex and time-consuming. In this study a two-step dual-label TRFIA was developed for the simultaneous detection of Lp-PLA and hsCRP in a single run. The performance of this assay was first evaluated using clinical serum samples, and then compared with commercialized kits. The sensitivity of this assay for Lp-PLA2 detection was 1ng/mL (dynamic range, 0-1000U/L), and the sensitivity for hsCRP detection was 1mg/L (dynamic range, 1-1000mg/L). High correlation coefficients (R) were obtained between the present dual-label TRFIA and commercially available kits(R=0.99 for LP-PLA2 and hsCRP). The present dual-label TRFIA has high sensitivity, specificity, and accuracy in clinical sample analysis. It is a good alternative to the single-label diagnostic methods.

摘要

动脉粥样硬化是大多数冠状动脉事件的根本原因。传统的冠状动脉粥样硬化检测方法是形态学检查或冠状动脉造影。这些方法复杂且耗时。在本研究中,开发了一种两步双标记时间分辨荧光免疫分析方法,用于在一次运行中同时检测Lp-PLA和hsCRP。首先使用临床血清样本评估该检测方法的性能,然后与商业化试剂盒进行比较。该检测方法对Lp-PLA2检测的灵敏度为1ng/mL(动态范围,0-1000U/L),对hsCRP检测的灵敏度为1mg/L(动态范围,1-1000mg/L)。本双标记时间分辨荧光免疫分析方法与市售试剂盒之间获得了高相关系数(R)(Lp-PLA2和hsCRP的R均为0.99)。本双标记时间分辨荧光免疫分析方法在临床样本分析中具有高灵敏度、特异性和准确性。它是单标记诊断方法的良好替代方法。

相似文献

1
A dual-label time-resolved fluorescence immunoassay (TRFIA) for screening of Coronary atherosclerosis based on simultaneous detection of Lp-PLA and HsCRP.一种基于同时检测脂蛋白相关磷脂酶A(Lp-PLA)和超敏C反应蛋白(HsCRP)的用于筛查冠状动脉粥样硬化的双标记时间分辨荧光免疫分析(TRFIA)。
Immunol Lett. 2017 Feb;182:12-17. doi: 10.1016/j.imlet.2016.12.004. Epub 2016 Dec 23.
2
Time-resolved Fluorescence Immunoassay (TRFIA) for the Simultaneous Detection of MMP-9 and Lp-PLA2 in Serum.时间分辨荧光免疫分析(TRFIA)法同时检测血清中 MMP-9 和 Lp-PLA2
J Fluoresc. 2021 Nov;31(6):1771-1777. doi: 10.1007/s10895-021-02811-3. Epub 2021 Sep 8.
3
The development of dual-label time-resolved fluorescence immunoassay (TRFIA) for screening of ovarian cancer based on simultaneous detection of human epididymis protein-4 and cancer antigen 125.基于同时检测人附睾蛋白4和癌抗原125的双标记时间分辨荧光免疫分析法用于卵巢癌筛查的研究进展
J Immunoassay Immunochem. 2016;37(5):453-62. doi: 10.1080/15321819.2015.1106950.
4
Time-resolved fluorescence immunoassay (TRFIA) for the simultaneous detection of hs-CRP and lipoprotein(a) in serum.时间分辨荧光免疫分析法(TRFIA)用于同时检测血清中的 hs-CRP 和脂蛋白(a)。
Biotechnol Appl Biochem. 2022 Dec;69(6):2617-2623. doi: 10.1002/bab.2310. Epub 2022 Jan 13.
5
A dual-label time-resolved fluorescence immunoassay for screening of osteoporosis based on simultaneous detection of C-terminal telopeptide (β-CTX) and aminoterminal propeptide (P1NP) of type I procollagen.一种基于同时检测I型前胶原C端肽(β-CTX)和I型前胶原氨基端前肽(P1NP)的用于骨质疏松症筛查的双标记时间分辨荧光免疫分析方法。
Scand J Clin Lab Invest. 2019 Feb-Apr;79(1-2):80-85. doi: 10.1080/00365513.2018.1555857. Epub 2019 Jan 12.
6
Establishment and clinical application of time-resolved immunofluorescence assay of lipoprotein-associated phospholipase A2.脂蛋白相关磷脂酶 A2 的时间分辨免疫荧光分析法的建立及其临床应用。
Anal Biochem. 2022 Jul 1;648:114674. doi: 10.1016/j.ab.2022.114674. Epub 2022 Mar 26.
7
Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.脂蛋白相关磷脂酶 A2 水平的解读受心脏病、合并症、动脉粥样硬化程度和治疗的影响。
Int J Cardiol. 2013 Sep 20;168(1):132-8. doi: 10.1016/j.ijcard.2012.09.054. Epub 2012 Oct 24.
8
Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.年轻成年人中脂蛋白相关磷脂酶A2与斑块负荷/成分的评估。
Coron Artery Dis. 2015 May;26(3):266-71. doi: 10.1097/MCA.0000000000000224.
9
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.脂蛋白相关磷脂酶 A2(Lp-PLA2)与急性冠状动脉综合征:与低密度脂蛋白胆固醇的关系。
Can J Cardiol. 2013 Dec;29(12):1679-86. doi: 10.1016/j.cjca.2013.09.026. Epub 2013 Oct 2.
10
Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.血清Lp-PLA2水平升高与冠状动脉疾病严重程度独立相关:一项中国人群的横断面研究
BMC Cardiovasc Disord. 2015 Feb 26;15:14. doi: 10.1186/s12872-015-0001-9.

引用本文的文献

1
A new method for screening acute/chronic lymphocytic leukemia: dual-label time-resolved fluorescence immunoassay.一种用于筛选急性/慢性淋巴细胞白血病的新方法:双标记时间分辨荧光免疫分析。
BMC Biotechnol. 2022 Sep 30;22(1):27. doi: 10.1186/s12896-022-00758-2.
2
Time-resolved Fluorescence Immunoassay (TRFIA) for the Simultaneous Detection of MMP-9 and Lp-PLA2 in Serum.时间分辨荧光免疫分析(TRFIA)法同时检测血清中 MMP-9 和 Lp-PLA2
J Fluoresc. 2021 Nov;31(6):1771-1777. doi: 10.1007/s10895-021-02811-3. Epub 2021 Sep 8.